Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation

Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation

Dendritic cell (DC)–based immunotherapies are believed to help eradicate residual tumor cells, including hepatocellular carcinoma (HCC). Here, we assessed the safety and clinical response to OK432-stimulated monocyte-derived DCs (MoDCs) in treating HCC after radiofrequency ablation (RFA). MoDCs were...

Full description

Bibliographic Details
Main Authors: Masaaki Kitahara, Eishiro Mizukoshi, Takeshi Terashima, Hidetoshi Nakagawa, Rika Horii, Noriho Iida, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Masao Honda, Yasunari Nakamoto, Shuichi Kaneko
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523319305388

Internet

http://www.sciencedirect.com/science/article/pii/S1936523319305388

Similar Items